Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical Mechanism of Endovascular Denervation (EDN) for the Treatment of Type 2 Diabetes

NCT05673668 is registered in ClinicalTrials.gov with Zhongda Hospital as lead sponsor.

NCT NCT05673668
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05673668 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical Mechanism of Endovascular Denervation (EDN) for the Treatment of Type 2 Diabetes
Lead sponsor
Zhongda Hospital
Phase
Not applicable
Overall status
Unknown status
Start date
December 27, 2022
Completion date
April 30, 2024
Enrollment
30 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

type 2 diabetes mellitus (t2dm)